RCT: Twice-Yearly Lenacapavir Prevents HIV Infections More Effectively Than Daily F/TAF in Women – N Engl J Med
SPECIALTIES,
Study Design and Population: This phase 3, double-blind, randomized controlled trial included 5,338 adolescent girls and young…